Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap24.34B
Enterprise Value23.33B
P/E Ratio21.02
PEG Ratio-1.96
Price/Sales Ratio3.77
Price/Book Ratio2.74
Enterprise/Revenue3.64
Enterprise/EBITDA16.55

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.18
Operating Margin0.19
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.13

Income Statement

Revenue5.85B
Revenue/Share6.06
Gross Profit4.04B
EBITDA1.44B
Net Income1.06B
Diluted EPS1.05

Balance Sheet

Total Cash3.74B
Total Cash/Share3.71
Total Debt415.13M
Total Debt/Equity0.05
Current Ratio6.22
Book Value Per Share8.28

Price History

52-Week Change-18.21
52-Week High27.9
52-Week Low17.96
Moving Average 50 Days21.98
Moving Average 200 Days22.09

Statistics

Average Volume11.32M
Shares Outstanding1.02B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield1.76
Payout Ratio0.7
Last Split Factor8:5
Last Split DateMay 12, 2017
AD